ConductScience.org, home

Paper17538160

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.

Temam S and 9 others. J Clin Oncol, 2007. Cited by 309 papers, by iCite.

Cite this record

ConductScience Library. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. Papers, record 17538160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17538160

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
PubMed
Journal
J Clin Oncol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
309
iCite
Relative citation ratio, by iCite
7.11
iCite
Revised in PubMed
2022-03-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Temam SStephane
2Kawaguchi HHidetoshi
3El-Naggar AKAdel K
4Jelinek JJaroslav
5Tang HHongli
6Liu DDDiane D
7Lang WWenhua
8Issa JPJean-Pierre
9Lee JJJ Jack
10Mao LLi

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
ErbB ReceptorsMajor topic
Gene DosageMajor topic
Head and Neck NeoplasmsMajor topic
MutationMajor topic
Adult
Aged
Aged, 80 and over
Female
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Male
Middle Aged

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA106451NCI NIH HHSUnited StatesP01CA106451PubMed and NIHNIH RePORTER
CA16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
P30CA016672NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17538157Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions.https://conductscience.org/library/papers/17538157

Source PubMed

Download CSV of comments and corrections

Cited by162

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 309 citations.

PMIDTitleJournalYearIn PapersSource
41474664Phytochemicals as Emerging Antiproliferative Agents in Head and Neck Cancer: Molecular Mechanisms and Therapeutic Strategies.Pharmacology2026https://conductscience.org/library/papers/41474664PubMed
41044775Interferon signaling and STING pathway in head and neck cancers: unlocking immune secrets and therapeutic frontiers.Cancer Cell Int2025https://conductscience.org/library/papers/41044775PubMed
40364160
EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers.
J Clin Med2025https://conductscience.org/library/papers/40364160PubMed
40301868Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study.BMC Oral Health2025https://conductscience.org/library/papers/40301868PubMed
39900969Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/39900969PubMed
39043526Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development.Int Dent J2025https://conductscience.org/library/papers/39043526PubMed
38920648Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas.Cells2024https://conductscience.org/library/papers/38920648PubMed
38873325Anti‑epidermal growth factor receptor monoclonal antibody therapy in locally advanced head and neck cancer: A systematic review of phase III clinical trials.Med Int (Lond)2024https://conductscience.org/library/papers/38873325PubMed
38536540Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.Mol Biol Rep2024https://conductscience.org/library/papers/38536540PubMed
38398017Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.Biomedicines2024https://conductscience.org/library/papers/38398017PubMed
37898690Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma.Sci Rep2023https://conductscience.org/library/papers/37898690PubMed
37559138Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.J Biomed Sci2023https://conductscience.org/library/papers/37559138PubMed
36835812Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma.J Clin Med2023https://conductscience.org/library/papers/36835812PubMed
36612264Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36612264PubMed
36454443Molecular pathways modulated by phytochemicals in head and neck cancer.J Cell Commun Signal2023https://conductscience.org/library/papers/36454443PubMed
36262474Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma.Front Mol Biosci2022https://conductscience.org/library/papers/36262474PubMed
36114912Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.Mol Divers2023https://conductscience.org/library/papers/36114912PubMed
36092724Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/36092724PubMed
36010285Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study.Diagnostics (Basel)2022https://conductscience.org/library/papers/36010285PubMed
35975731The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma.Cancer Med2023https://conductscience.org/library/papers/35975731PubMed

See all 162 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17538160

GET https://conductscience.org/api/papers/v1/17538160/cited_by?page=2